CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Planned sale Director sold 10,000 shares at $22.00 ($220,000)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SENIOR VICE PRESIDENT, R&D sold 8,951 shares at $19.78 ($177,051)
- 4 Planned sale SVP, GC & CORPORATE SECRETARY sold 8,951 shares at $19.78 ($177,051)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 50,691 shares at $20.21 ($1,024,343)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,273 shares at an average $20.12 ($106,082)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 5,166 shares at $20.12 ($103,940)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 5,192 shares at $20.12 ($104,463)
- 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 3,348 shares at $20.12 ($67,362)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 14 of 65 · 1,286 filings